Study Highlights Promise, Questions in Quest for Stem Cell-based MS Treatments
AUGUST 24, 2017
Jared Kaltwasser
A promising report from India appears to bolster the case that stem cell therapies might one day reverse the progression of multiple sclerosis (MS), but experts say there remain many more questions than answers when it comes to the potential treatment option.
Earlier this month, Indian research firm Advancells announced the results of a single-patient pilot study. The firm said they used an autologous adult stem cell therapy to successfully reverse MS symptoms in a patient from New Zealand.
The patient said he was able to regain the ability to climb stairs following the procedure, something he hadn’t done in five years. The company says they plan to track MRI scans and other data over the next several months in order to understand and document the full impact of the treatment on the disease.
Despite the apparent improvement in symptoms for the Advancells patient, researchers say there’s still much not know about stem cell-based therapies.
Bruce Bebo (pictured), PhD, the executive vice president of research at the National Multiple Sclerosis Society, said it’s far too early to be able to draw any concrete conclusions about the promise of stem cell treatments for MS.
Artificial intelligence creates content for the site, no worse than a copywriter, you can also use it to write articles. 100% uniqueness :). Click Here:👉 https://stanford.io/3FXszd0